|
|
| An Address from Chairman of the Board |
 |
China National Pharmaceutical Group Corporation (Sinopharm)， as a national healthcare industrial platform, is a comprehensive enterprise consisting of R&D, manufacture, distribution and logistics all together. Under the bright leadership of SASAC, with big support from the national industrial policy and local government, Sinopharm achieved rapid development and made significant contribution to Chinese healthcare industry.
Sinopharm, based on the enterprise culture of ‘Caring for Life, Attending to Health’, is committed to build a team with social responsibility, and has gained trust from market users and the society with high-class work performance, excellent management and upstanding services.
|
Since China is entering a new historical era of scientific development and transformation of economic growth, Sinopharm is aiming to promote the healthcare industrial growth and provide affordable quality drugs to most of the citizens, through building a central enterprise healthcare platform with international competitiveness as its own commitment, establishing the ‘Big Pharma’ concept within the healthcare sector, making all effort to construct a new platform for R&D innovations, being active in the construction and development of the big bases for biological pharmaceuticals, modern pharmaceuticals and national medicines; through accomplishing the distribution and logistics network, improving technological innovation, capital operation, consolidation and reorganization, to make the company qualified into the World Top 500 and establish the status of Chinese enterprise in the international pharmaceutical sector.
Sinopharm is actively building a learning organization, using ‘Learning, Harmony, Responsibility’ as the fundamental thought of the team construction. Sinopharm is also an open enterprise, it largely encourages learning, communication and integration with the same occupations within and beyond China, to make joint effort on the development of Chinese pharmaceutical industry and the health undertaking of human race. |
|
|
|
|
| |